BOLT - Total Utang marang Modal Bolt Biotherapeutics, Inc.

Logo perusahaan publik Bolt Biotherapeutics Inc. (BOLT)

Bolt Biotherapeutics relies on patent protection for its developments in targeted tumor therapy, receiving support from specialized investment funds. In US laboratories, Bolt Biotherapeutics creates innovative drugs based on the Boltbody system to stimulate the immune response. The recruitment of leading immunologists and scientists through stock option programs complements the share price visualized below, where the debt-to-equity ratio stands at 1.70.

BOLT: Total Utang marang Modal Bolt Bio 04.07.2022 - 29.10.2026

Rincian analitis perusahaan Bolt Biotherapeutics

- rega lan prakiraan konsensus rega:
Bagan rega Bolt Biotherapeutics Inc.|BOLT - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Bolt Biotherapeutics|BOLT - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Bolt Biotherapeutics|BOLT - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku boltbio.com|BOLT - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Bolt Biotherapeutics|BOLT - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Bolt Biotherapeutics Inc.|BOLT - Gunggung utang perusahaan|Utang marang nilai buku Bolt Biotherapeutics|BOLT - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Bolt Biotherapeutics|Likuiditas cepet boltbio.com
- informasi bathi lan kelipatan valuasi:
BOLT - Penghasilan resik
Analisis dhasar perusahaan:Bolt Biotherapeutics
Barang utama Bolt Biotherapeutics, Inc.

For Bolt Biotherapeutics (BOLT), the financial risk indicator (debt-to-equity) reflects balance sheet resilience during a period of strict resource optimization and refocusing on its priority oncology drug. This metric is calculated as the ratio of total liabilities to equity, measuring the business's degree of dependence on external borrowings, which allows investors to assess bankruptcy risk in the event of a liquidity shortage.

Analisis pesaing Bolt Biotherapeutics

Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|Pieris Pharmaceuticals Inc - Total Utang marang Modal|SVRA: Utang marang Ekuitas|Rigel Pharmaceuticals (RIGL) - Utang marang Ekuitas|Utang marang Modal anaptysbio.com (ANAB)|Utang marang Ekuitas Astria Therapeutics, Inc.|Utang marang Ekuitas ENGN|Rasio Total Utang marang Ekuitas RAPT (RAPT Therapeutics, Inc.)|Utang Agregat marang Modal JBIO|Aclaris Therapeutics - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi KYTX|Tiziana Life Sciences Ltd - Total Utang marang Modal|CABA: Utang marang Ekuitas|VTYX: Total Utang marang Modal|THTX - Koefisien Total Utang marang Modal|Utang marang Ekuitas Avalo Therapeutics, Inc|Utang marang Modal eledon.com ELDN|Rasio Total Utang marang Ekuitas AGEN (Agenus Inc.)|Utang Agregat marang Modal CLYM|Total Utang marang Modal ZURA (Zura Bio Limited)|Rasio Kabeh Utang marang Dana Pribadi ATYR|Adagene Corp - Total Utang marang Modal|Utang marang Modal ImageneBio Inc|shattucklabs.com (STTK) - Utang marang Ekuitas|Equillium - Rasio Kabeh Utang marang Dana Pribadi|CNTB (Connect Biopharma Holdings) - Total Utang marang Modal|Total Utang marang Modal Immunic Inc|Utang marang Ekuitas Atara Biotherapeutics (ATRA)|IFRX: Utang Agregat marang Ekuitas|Total Utang marang Modal XFOR (X4 Pharmaceuticals, Inc.)|Adicet Bio Inc. (ACET) - Utang marang Modal|CELU: Rasio Total Utang marang Ekuitas|INMB - Total Utang marang Modal|BRNS (Barinthus Biotherapeutics) - Rasio Total Utang marang Ekuitas|KZR: Utang Agregat marang Modal|SABS (SAB Biotherapeutics, Inc.) - Total Utang marang Modal|Akari Therapeutics PLC (AKTX) - Koefisien Total Utang marang Modal|Total Utang marang Modal ENLV|Rasio Total Utang marang Ekuitas q32bio.com QTTB|Utang marang Ekuitas GeoVax Labs, Inc. GOVX|Koefisien Total Utang marang Modal edesabiotech.com (EDSA)|iBio - Total Utang marang Modal|CARM: Utang marang Ekuitas|XTL Biopharmaceuticals, Ltd. (XTLB) - Utang marang Ekuitas|Utang marang Modal HCW Biologics (HCWB)|Utang marang Ekuitas Aptevo Therapeutics, Inc.|Utang marang Ekuitas AIM|Rasio Total Utang marang Ekuitas ADTX (Aditxt)|Utang Agregat marang Modal GRI|Utang marang Ekuitas XORTX XRTX|HIND (Vyome Therapeutics) - Utang Agregat marang Ekuitas|Revelation Biosciences - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi INDP (indaptusrx.com)|SCNI: Total Utang marang Modal|CalciMedica (CALI) - Total Utang marang Modal|Utang marang Ekuitas Affimed NV|ALLK: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas HOOKIPA Pharma Inc. (HOOK)|Rasio Total Utang marang Ekuitas igmbio.com IGMS|Total Utang marang Modal ITOS (iTeos Therapeutics, Inc.)|Total Utang marang Modal Ocean Biomedical Inc OCEA|TCBP: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi THRD (Third Harmonic Bio Inc)